Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Concordia Healthcare Corp. T.CXR.R

Healthcare Biotechnology


TSX:CXR.R - Post by User

Concordia Healthcare Corp. > Not Sounding good on BNN
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(288)
•••
Comment by rad10on Feb 07, 2017 2:32pm
350 Views
Post# 25811703

RE:RE:Not Sounding good on BNN

RE:RE:Not Sounding good on BNN
MustardTiger88 wrote: Forget BNN.  For the first half of 2016 they brought people in who pumped this stock like it was stupid not to buy it.  I heard a bunch of the analysts they had on either did a complete 180 or went silent about it.

Whiskeytime wrote: https://www.bnn.ca/video/brendan-caldwell-discusses-concordia-vs-valeant~1047916




True where is the pumper in chief Jason Donville? - havent heard a squeak from him in months......................

<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities